鉴定KHS-101作为转录因子EB激活剂,以促进α-同核素降解
Haizhen Zhu1, Anqi Ren1, Ting Li1
1Nanhu Laboratory, State Key Laboratory of Biomedical Analysis (SKLBA, Formerly Known as National Center of Biomedical Analysis, NCBA), Beijing 100039, China.
International journal of molecular sciences
|January 28, 2026
概括
研究人员发现了KHS-101,一种新型化合物,可以激活转录因子EB (TFEB). 这种TFEB激活增强细胞清除机制,显示治疗神经退行性疾病如帕金森病的希望.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经退行性疾病与 lysosomal 功能受损有关.
- 转录因子EB (TFEB) 调节细胞清除途径,包括溶酶体生物发生和自.
- 加强TFEB活动为这些疾病提供了潜在的治疗策略.
研究的目的:
- 为了确定TFEB的新型激活剂.
- 在神经退行性疾病的细胞模型中评估新型TFEB激活剂KHS-101的治疗潜力.
主要方法:
- 血液-大脑屏障-可穿透的小分子的高通量选.
- 测试用于测量TFEB核转位,溶酶体生物发生和自流.
- 帕金森病的细胞模型使用A53T突变α-synuclein.
主要成果:
- 鉴定出KHS-101是一种新的TFEB激活剂.
- KHS-101增强了TFEB的核转位,溶酶体功能和自流.
- 在帕金森病细胞模型中,KHS-101加速了致病性α-synuclein的降解.
结论:
- KHS-101是一种强大的TFEB激活剂.
- 通过TFEB激活调节自-溶酶体通路,对帕金森病和相关的神经退行性疾病具有治疗潜力.
相关概念视频
Transcription Factors
82.7K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K
Transcription Elongation Factors
13.8K
Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
13.8K
Transcription Elongation Factors
4.8K
4.8K
Eukaryotic Transcription Activators
12.8K
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.8K
Prokaryotic Transcriptional Activators and Repressors
25.4K
The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
Transcription of prokaryotic...
25.4K
General Transcription Factors
7.0K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
7.0K


